The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's current EPS (TTM) is โน1,209. In 2022 the company made an earnings per share (EPS) of โน1,040 an increase over its 2021 EPS that were of โน885.00.
Year | EPS | Change |
---|---|---|
2023 (TTM) | โน1,167 | 12.17% |
2022 | โน1,040 | 17.57% |
2021 | โน885.00 | -16.38% |
2020 | โน1,058 | -4.32% |
2019 | โน1,106 | 2.05% |
2018 | โน1,084 | 382.51% |
2017 | โน224.67 | -74.52% |
2016 | โน881.59 | 12.66% |
2015 | โน782.49 | 34.9% |
2014 | โน580.04 | 0.74% |
2013 | โน575.76 | 20.36% |
2012 | โน478.38 | 37.93% |
2011 | โน346.83 | -15.77% |
2010 | โน411.75 | 6.4% |
2009 | โน386.98 | 19.84% |
2008 | โน322.91 | 35% |
2007 | โน239.19 | 12% |
2006 | โน213.56 | -15.54% |
2005 | โน252.86 | 59.14% |
2004 | โน158.89 | 6.9% |
2003 | โน148.64 | -289.13% |
2002 | -โน78.59 | -186.79% |
2001 | โน90.55 | -4.5% |
2000 | โน94.82 | 4.72% |
1999 | โน90.55 | 23.98% |
1998 | โน73.04 | 40.16% |
1997 | โน52.11 | 2.52% |
1996 | โน50.83 |